Status:
COMPLETED
Immune Function of Infants With HIV
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
Up to 24 years
Brief Summary
This observational study will evaluate data from infants born to HIV infected mothers in order to better characterize disease progression in early HIV infection.
Detailed Description
The role of HIV-specific cytotoxic T-lymphocytes (CTL) in controlling viremia and protecting against disease progression following vertical infection may be dependent upon CTL functional responses as ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Infants and children born to HIV infected women
Exclusion
Key Trial Info
Start Date :
July 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2005
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00073229
Start Date
July 1 2000
End Date
June 1 2005
Last Update
September 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01605